SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

COAR is a community-driven meme token on the Solana blockchain built around the theme of oil and energy. The project brings together a growing community of crypto enthusiasts who share an interest in energy-themed digital assets. COAR operates as a fully decentralized token with active trading on Solana decentralized exchanges. The token has a fixed maximum supply of 1 billion units with 6 decimal places, and its mint authority has been permanently revoked, making the supply immutable. The project features a dedicated website at coargov.com with real-time market data integration via DexScreener.

Chinese Oil Asset Reserve

COAR is gaining momentum as investors rally around its unconventional blend of oil tokenization, geopolitical themes, and viral social media narratives. Community members are actively debating the project's unique positioning and its potential to capture attention through highly speculative, meme-driven marketing.

Invesco Exchange-Traded Fund Trust II - Invesco S&P 500 Momentum ETF

Invesco S&P 500 Momentum ETF

The Invesco S&P 500 Momentum ETF is trending as investors debate its role as a core portfolio holding, frequently highlighting its historical tendency to outperform traditional S&P 500 benchmarks over longer periods. Community discussions center on the pros and cons of its semi-annual rebalancing strategy, with some users favoring it as a "set it and forget it" momentum play, while others weigh it against more actively managed or frequently rotating alternatives.

Bill Holdings, Inc. engages in the provision of cloud-based software solutions. The firm simplifies, digitizes, and automates complex back-office financial operations for small and midsize businesses. Its software helps customers generate and process invoices, streamline approvals, send and receive payments, sync with their accounting systems and manage their cash. The company was founded by Rene Lacertea in April 2006 and is headquartered in San Jose, CA.

BILL Holdings Inc

Bill.com Holdings Inc

Bill.com Holdings is trending due to persistent speculation regarding a potential buyout, bolstered by active interest from activist investors like Starboard Value and Elliott Investment Management. The community remains heavily divided, with many traders holding for a premium acquisition while others express frustration over the stock's stagnant performance and valuation pressure.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is attracting significant community attention as a key player in the decentralized perpetual exchange sector, with investors closely watching its high transaction volume and potential for market share expansion. The broader conversation is heavily influenced by its integration into institutional portfolios, upcoming token unlock schedules, and its ongoing role as a preferred venue for trading during periods of high geopolitical and market volatility.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as retail investors capitalize on high-volatility price swings within the biotech sector, heavily influenced by leveraged trading strategies and ongoing community speculation regarding potential buyouts and FDA-related catalysts. Sentiment remains polarized between traders betting on sustained sector momentum driven by AI-led drug discovery and those anticipating a sharp mean reversion as leveraged decay impacts long-term holdings.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is trending as investors capitalize on its deep ties to the Hyperliquid ecosystem and the strong performance of its HYPE token treasury. The community is actively debating the stock's role as a high-beta infrastructure proxy while navigating ongoing questions about NAV discounts and potential rotation from crypto-adjacent assets.

Waste Management, Inc. is a holding company, which engages in the provision of waste management environmental services. It operates through the following segments: Collection and Disposal-East Tier (East Tier), Collection and Disposal-West Tier (West Tier), Recycling Processing and Sales, Renewable Energy, and Healthcare Solutions. The East Tier segment includes the Eastern United States, the Great Lakes Region, and Canada. The West Tier segment refers to the upper Midwest region and British Columbia, Canada. The Recycling Processing and Sales segment focuses on the processing and sales of materials collected from residential, commercial, and industrial customers. The Renewable Energy segment develops, operates, and promotes projects for landfill gas use. The Healthcare Solutions segment relates to its primarily business to business company providing services that protect people and brands, promote health and well-being and safeguard the environment. The company was founded on September 30, 1987 and is headquartered in Houston, TX.

Waste Management, Inc.

Waste Management is attracting significant investor attention as a defensive "Steady Eddie" play amid broader market volatility, with community discussions centering on its essential service model, consistent dividend growth, and potential for margin expansion through AI integration and renewable natural gas. Investors are particularly focused on the stock's resilience during economic uncertainty, often comparing its stability to cyclical sectors while monitoring recent management efforts to optimize costs and operations.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

The community is actively debating the future of the biotechnology sector, with many investors closely monitoring XBI technical levels as a primary catalyst for trading the leveraged LABD ETF. Sentiment remains divided between those positioning for a potential sector reversal and those frustrated by continued bullish strength in biotech assets.

Analog Devices, Inc. is a semiconductor company, which engages in the combination of analog, digital, and software technologies into engineering solutions. Its products include analog and mixed signals, power management and reference, amplifiers radio frequency, and reference, sensors and actuators, and digital signal processing and system. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Analog Devices Inc.

Analog Devices is trending as investors monitor its position in the semiconductor cycle following a series of analyst upgrades and active discussions about whether the stock represents a defensive play or a value-driven growth opportunity. The community is focused on the balance between recent price momentum, its role in AI infrastructure, and the potential for a broader rebound in the industrial and automotive chip segments.

iShares Gold Trust is an investment vehicle, which engages in owning gold transferred to the trust in exchange for shares issued by the trust. Its activities include issuing baskets of shares in exchange for the gold deposited with the custodian as consideration; selling gold as necessary to cover the sponsor’s fee, trust expenses not assumed by the sponsor and other liabilities; and delivering gold in exchange for baskets surrendered for redemption. The company was founded on January 21, 2005 and is headquartered in San Francisco, CA.

iShares Gold Trust - fractional undivided beneficial interests

iShares Gold Trust

iShares Gold Trust is capturing significant investor attention as gold prices hover near record highs, driven by a combination of strong central bank accumulation, ongoing geopolitical instability, and a broader flight to safety amid debt concerns. Community members remain deeply divided between those viewing the move as a sustainable structural bull market and those warning of technical overextension and potential short-term volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Data Analyses Presented at Heart Failure 2026 Demonstrate Robust and Consistent Clinical Benefit of Vutrisiran as a First-Line Treatment Option Across ATTR-CM Patient Populations, Including Patients with a High Disease Burden

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new analyses from the HELIOS-B Phase 3 study of vutrisiran in patients with the cardiomyopathy of...

Alnylam to Webcast Presentations at Upcoming Investor Conferences

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following upcoming investor conferences: BofA Securities Healthcare Conference on Wednesday, May 13, 2026, at 10:40 am PT (1:40 pm ET) in Las...

Bronte Capital Management Pty Ltd. Has $15.45 Million Position in Alnylam Pharmaceuticals, Inc. $ALNY

Bronte Capital Management Pty Ltd. boosted its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 11.1% in the 4th quarter, according to the company in its most recent filing...

Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type...

PFA Pension Forsikringsaktieselskab Buys Shares of 35,405 Alnylam Pharmaceuticals, Inc. $ALNY

PFA Pension Forsikringsaktieselskab bought a new stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 35,405 shares of the biopharmaceutical company's stock, v...

PKO Investment Management Joint Stock Co Increases Holdings in Alnylam Pharmaceuticals, Inc. $ALNY

PKO Investment Management Joint Stock Co boosted its stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 750.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,800 shares of the biopharmaceutical company's stock afte...

Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS trimmed its holdings in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) by 53.1% during the fourth quarter, according to its most recent Form...

Royal Bank Of Canada Has Lowered Expectations for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price

Royal Bank Of Canada lowered their price objective on Alnylam Pharmaceuticals from $450.00 to $445.00 and set an "outperform" rating for the company in a research report on Friday...

Alnylam Q1 Earnings Beat Estimates, Amvuttra Sales Drive Y/Y Growth

ALNY beats Q1 earnings and revenue estimates as Amvuttra sales surge 187%, driving 96% revenue growth and offsetting declines in collaborator revenue and Onpattro sales.

Wells Fargo & Company Issues Positive Forecast for Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Price

Wells Fargo & Company increased their target price on shares of Alnylam Pharmaceuticals from $376.00 to $377.00 and gave the stock an "equal weight" rating in a research note on Friday...

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002, and is headquartered in Cambridge, MA.

Current Price	$286.98
Prev Close	$293.45
Open	$294.78
Dividend Yield	0.00%
50-Day Moving Average	$312.86
Beta	0.84
Avg. Volume	1.11M
PE Ratio	68.19

52-Week High	$495.55
52-Week Low	$284.19
Market Capitalization	$38.32B
EPS (Annual)	$2.33
Price to Book	35.61
Revenue Per Employee	$1.49M

ALNY
Alnylam Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALNY News

ALNYAlnylam Pharmaceuticals Inc